These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15671532)

  • 1. Immunoglobulin superfamily receptor translocation associated 2 protein on lymphoma cell lines and hairy cell leukemia cells detected by novel monoclonal antibodies.
    Ise T; Maeda H; Santora K; Xiang L; Kreitman RJ; Pastan I; Nagata S
    Clin Cancer Res; 2005 Jan; 11(1):87-96. PubMed ID: 15671532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sandwich ELISAs for soluble immunoglobulin superfamily receptor translocation-associated 2 (IRTA2)/FcRH5 (CD307) proteins in human sera.
    Ise T; Kreitman RJ; Pastan I; Nagata S
    Clin Chem Lab Med; 2006; 44(5):594-602. PubMed ID: 16681430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IRTA1 and IRTA2, novel immunoglobulin superfamily receptors expressed in B cells and involved in chromosome 1q21 abnormalities in B cell malignancy.
    Hatzivassiliou G; Miller I; Takizawa J; Palanisamy N; Rao PH; Iida S; Tagawa S; Taniwaki M; Russo J; Neri A; Cattoretti G; Clynes R; Mendelsohn C; Chaganti RS; Dalla-Favera R
    Immunity; 2001 Mar; 14(3):277-89. PubMed ID: 11290337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.
    Du X; Nagata S; Ise T; Stetler-Stevenson M; Pastan I
    Blood; 2008 Jan; 111(1):338-43. PubMed ID: 17895404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies.
    Bandoh N; Ogino T; Cho HS; Hur SY; Shen J; Wang X; Kato S; Miyokawa N; Harabuchi Y; Ferrone S
    Tissue Antigens; 2005 Sep; 66(3):185-94. PubMed ID: 16101829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma.
    Palomba ML; Roberts WK; Dao T; Manukian G; Guevara-Patiño JA; Wolchok JD; Scheinberg DA; Houghton AN
    Clin Cancer Res; 2005 Jan; 11(1):370-9. PubMed ID: 15671568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies elicited by naked DNA vaccination against the complementary-determining region 3 hypervariable region of immunoglobulin heavy chain idiotypic determinants of B-lymphoproliferative disorders specifically react with patients' tumor cells.
    Rinaldi M; Ria F; Parrella P; Signori E; Serra A; Ciafrè SA; Vespignani I; Lazzari M; Farace MG; Saglio G; Fazio VM
    Cancer Res; 2001 Feb; 61(4):1555-62. PubMed ID: 11245465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New monoclonal antibodies to mesothelin useful for immunohistochemistry, fluorescence-activated cell sorting, Western blotting, and ELISA.
    Onda M; Willingham M; Nagata S; Bera TK; Beers R; Ho M; Hassan R; Kreitman RJ; Pastan I
    Clin Cancer Res; 2005 Aug; 11(16):5840-6. PubMed ID: 16115924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-CD30-scFv-Fc-IL-2 antibody-cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells.
    Heuser C; Guhlke S; Matthies A; Bender H; Barth S; Diehl V; Abken H; Hombach A
    Int J Cancer; 2004 Jun; 110(3):386-94. PubMed ID: 15095304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular immunotherapy for follicular lymphoma using genetically modified CD20-specific CD8+ cytotoxic T lymphocytes.
    Wang J; Press OW; Lindgren CG; Greenberg P; Riddell S; Qian X; Laugen C; Raubitschek A; Forman SJ; Jensen MC
    Mol Ther; 2004 Apr; 9(4):577-86. PubMed ID: 15093188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of intracytoplasmic immunoglobulin by flow cytometry in B-cell malignancies.
    Bardales RH; Al-Katib AM; Carrato A; Koziner B
    J Histochem Cytochem; 1989 Jan; 37(1):83-9. PubMed ID: 2491755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibody SN10 which shows a highly selective reactivity with human B leukemia-lymphoma and is effectively internalized into cells.
    Takeuchi T; Barcos MP; Seon BK
    Cancer Res; 1991 Jun; 51(11):2985-93. PubMed ID: 1709587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cloning of human Smac gene and its pro-apoptotic effect on Burkitt's lymphoma cells].
    Lu C; Wu SH; Chen JQ; Zhao F; Chi X; Pan XQ; Fei L; Guo M; Huang SM; Guo XR; Chen RH
    Zhonghua Er Ke Za Zhi; 2005 Jul; 43(7):503-6. PubMed ID: 16083549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XAGE-1 expression in non-small cell lung cancer and antibody response in patients.
    Nakagawa K; Noguchi Y; Uenaka A; Sato S; Okumura H; Tanaka M; Shimono M; Ali Eldib AM; Ono T; Ohara N; Yoshino T; Yamashita K; Tsunoda T; Aoe M; Shimizu N; Nakayama E
    Clin Cancer Res; 2005 Aug; 11(15):5496-503. PubMed ID: 16061866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
    Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
    Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics.
    Korver W; Singh S; Liu S; Zhao X; Yonkovich S; Sweeney A; Anton K; Lomas WE; Greenwood R; Smith A; Tran DH; Shinkawa P; Jimenez M; Yeung P; Aguilar G; Palencia S; Vatta P; Mueller M; Zhan X; Newton EM; Liu Y; Zhao J; Emtage P; Levy MD; Hsi ED; Funk WD; Abo A
    Br J Haematol; 2007 May; 137(4):307-18. PubMed ID: 17456053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional humanization of an anti-CD30 Fab fragment for the immunotherapy of Hodgkin's lymphoma using an in vitro evolution approach.
    Schlapschy M; Gruber H; Gresch O; Schäfer C; Renner C; Pfreundschuh M; Skerra A
    Protein Eng Des Sel; 2004 Dec; 17(12):847-60. PubMed ID: 15708864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two monoclonal antibodies defining unique antigenic determinants on human B-lymphoma cells.
    Howard DR; Eaves AC; Takei F
    Cancer Res; 1985 Dec; 45(12 Pt 1):6322-7. PubMed ID: 2415242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.